Automatic Implantable Cardioverter-Defibrillator (AICD)
Customize your policy alerts
Sign up for Geisinger Health Plan Policy MP140 alerts
Get alerted when Policy MP140 changes without checking for updates manually.
Monitor payer policy activity
Defines Geisinger Health Plan coverage, coding, and prior authorization expectations for implantation, replacement, and related services for automatic implantable cardioverter-defibrillators across applicable lines of business.
No material clinical or coverage changes in this revision.
Coverage Criteria for AICD
General Coverage Prerequisites
Covered when authorization criteria are met and services are medically necessary per plan definitions and Cohere clinical criteria.
Cohere utilizes proprietary clinical criteria, utilization management decision-support tools, and evidence-based guidelines to adjudicate requests; for Medicare, applicable LCDs/NCDs supersede this policy.
Coverage for experimental or investigational treatments, services, and procedures is specifically excluded under the member's certificate with Geisinger Health Plan. Unproven services performed outside of an approved clinical trial are also specifically excluded.
Services that are identified as experimental, investigational, or unproven per policy MP015 are considered not covered / not medically necessary under the member's certificate and are excluded from coverage.
Procedure and Device Codes
| 0571T | Insertion of substernal implantable defibrillator electrode |
| 0572T | Insertion or replacement of implantable cardioverter-defibrillator system with substernal electrode(s) (as referenced) |
| C1721 | Cardioverter-defibrillator, dual chamber (implantable) |
| C1777 | Lead, cardioverter-defibrillator, endocardial single |
| C1779 | Lead, pacemaker, transvenous VDD single pass / Pacemaker, dual chamber, rate-responsive (implantable) (as referenced) |
| C1882 | Cardioverter-defibrillator, other than single or dual chamber (implantable) |
| C1895 | Lead, cardioverter-defibrillator, endocardial dual |
| C1896 | Lead, cardioverter-defibrillator, other than endocardial single or dual coil (implantable) |
| C1898 | Lead, pacemaker, other than transvenous VDD single pass |
| C1899 | Lead, pacemaker/cardioverter-defibrillator combination (implantable) |
| C1900 | Lead, left ventricular coronary venous system |
| C2619 | Pacemaker, dual chamber, nonrate-responsive (implantable) |
| C2620 | Pacemaker, single chamber, nonrate-responsive (implantable) |
| C2621 | Pacemaker, other than single or dual chamber (implantable) |
| K0606 | Automatic external defibrillator, with integrated electrocardiogram analysis, garment type |
| K0607 | Replacement battery for automated external defibrillator, garment type only, each |
| 33216 | Insertion of a single transvenous electrode, permanent pacemaker or implantable defibrillator |
| 33217 | Insertion of 2 transvenous electrodes, permanent pacemaker or implantable defibrillator |
| 33224 | Insertion of pacing electrode, cardiac venous system, for left ventricular pacing, with attachment to previously placed pacemaker or implantable defibrillator pulse generator |
| 33230 | Insertion of pacing implantable defibrillator pulse generator only; with existing dual leads |
| 33231 | Insertion of pacing implantable defibrillator pulse generator only; with existing multiple leads |
| 33240 | Insertion of implantable defibrillator pulse generator only; with existing single lead |
| 33241 | Removal of implantable defibrillator pulse generator only |
| 33244 | Removal of single or dual chamber implantable defibrillator electrode(s); by transvenous extraction |
| 33249 | Insertion or replacement of permanent implantable defibrillator system with transvenous lead(s), single or dual chamber |
| 33264 | Removal of implantable defibrillator pulse generator with replacement of implantable defibrillator pulse generator; multiple lead system |
Prior Authorization and Submission Requirements
Prior authorization through Cohere required
Geisinger Health Plan requires prior authorization through Cohere for Cardiology services for members enrolled in its Commercial HMO and PPO, Medicare Advantage, GHP Family Medicaid and CHIP products. Cohere applies proprietary clinical criteria, utilization management decision‑support tools, and evidence‑based guidelines when adjudicating requests. For details on which services require prior authorization, refer to the payer portal.
- Submit PA requests via the Cohere prior authorization system.
- Cohere will use its proprietary clinical criteria and decision‑support tools to determine medical necessity.
Medicaid PA requests may be evaluated case‑by‑case
For the PA Medicaid business segment, any requests that do not meet the PARP criteria may be evaluated on a case‑by‑case basis. Providers should submit full clinical information with the PA request to support a case‑by‑case review when PARP criteria are not met.
- Case‑by‑case review available only for PA Medicaid segment when PARP criteria are not satisfied.
Submit applicable procedural and device codes with PA requests
When requesting authorization, submit the applicable procedural and device codes listed in this policy to support the request; the coding lists are provided for informational purposes to support authorization submission and do not guarantee coverage or payment.
- Include relevant CPT and HCPCS codes from the policy (see device and procedure code groups).
- Note: inclusion of a code in the list does not imply coverage or reimbursement; Medicare business segment may have specific CPT/HCPCS coverage rules.
Risk of denial or nonpayment without Cohere prior authorization
Failure to obtain prior authorization through Cohere for Cardiology services for members in Commercial HMO/PPO, Medicare Advantage, GHP Family Medicaid and CHIP may result in denial or non‑coverage per plan requirements.
- Providers risk claim denial or nonpayment if Cohere prior authorization is not obtained when required.
Background
An automatic implantable cardioverter‑defibrillator (AICD) is an electronic device that continuously monitors heart rhythm, recognizes life‑threatening ventricular arrhythmias such as ventricular fibrillation and ventricular tachycardia, and automatically delivers an electrical shock to terminate the arrhythmia. AICDs reduce the risk of sudden cardiac death and may be combined with cardiac resynchronization therapy when indicated for heart failure with conduction abnormalities.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.